Search - tctmd.com

Displaying 1 - 20 of 52

Sort: Relevancy | Date

News Daily News

NOACs Significantly Curb Risk of VTE in Cancer Patients

L.A. McKeown

December 06, 2018

News Daily News

Opioid Use Does Not Impart Higher In-Hospital Mortality for Cardiac Surgery Patients

Caitlin E. Cox

December 06, 2018

News Conference News AHA 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

Todd Neale

November 11, 2018

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

News Daily News

Automated Email Reminders May Boost IVC Filter Retrieval, Cut Complications

Todd Neale

October 23, 2018

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

Todd Neale

October 12, 2018

News Daily News

GALILEO Trial of Rivaroxaban After TAVR Stopped Early for Harm

Todd Neale

October 09, 2018

Presentation TCT Abstracts Posters 2018

Pulmonary Embolism Severity Index (PESI) is a Predictor of Mid-Term Death After Mechano-Pharmacological Treatment of Acute Pulmonary Embolism

Presenter: D. Vasilev

September 25, 2018

Presentation TCT Abstracts Posters 2018

Hemodynamic Characteristics and Response to Catheter-Directed Lysis in Patients Presenting with Submassive Pulmonary Embolism

Presenter: Lindsey Cilia

September 25, 2018

Presentation TCT 2018

Special Topic: What Is the Role of Balloon Pulmonary Angioplasty for Treatment of CTEPH?

Presenter: Robert A. Lookstein, Akhilesh K. Sista, Ehtisham Mahmud

September 24, 2018

Presentation TCT 2018

When to Employ Advanced Therapies in PE?

Presenter: Robert A. Lookstein, Akhilesh K. Sista, Jay S. Giri

September 24, 2018

Presentation TCT 2018

Emerging Catheter-Based Techniques to Treat Acute Pulmonary Embolism

Presenter: Robert A. Lookstein, Akhilesh K. Sista

September 24, 2018

Presentation TCT 2018

Data for Lytic Therapy in Massive and Submassive Pulmonary Embolism

Presenter: Robert A. Lookstein, Akhilesh K. Sista

September 24, 2018

Presentation TCT 2018

Acute Pulmonary Embolism: How Big Is the Problem and How to Start a PERT

Presenter: Robert A. Lookstein, Akhilesh K. Sista, Teresa L. Carman

September 24, 2018

News Conference News TCT 2018

Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure

Todd Neale

September 23, 2018

Presentation TCT 2018

Case #1 Conclusion: A Patient With Massive PE How Did We Treat?

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Vikas Aggarwal, Mahir Elder, Jay S. Giri, Gregory Piazza, Akhilesh K. Sista

September 23, 2018

Presentation TCT 2018

The Case for ECMO or Other RV Support as the Ideal Treatment for Massive PE!

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Mahir Elder

September 23, 2018

Presentation TCT 2018

The Case for Surgical Therapy for Massive PE as the First-line Therapy!

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Marisa Cevasco

September 23, 2018

Presentation TCT 2018

The Case for Catheter-based Therapy for Massive PE as the Principal Approach!

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Akhilesh K. Sista

September 23, 2018

Presentation TCT 2018

Case #2 Introduction: A Patient With Massive PE How Should We Treat?

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Vikas Aggarwal, Mahir Elder, Jay S. Giri, Gregory Piazza, Akhilesh K. Sista

September 23, 2018

Advertisement

NOACs Significantly Curb Risk of VTE in Cancer Patients

Opioid Use Does Not Impart Higher In-Hospital Mortality for Cardiac Surgery Patients

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

Automated Email Reminders May Boost IVC Filter Retrieval, Cut Complications

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

GALILEO Trial of Rivaroxaban After TAVR Stopped Early for Harm

Pulmonary Embolism Severity Index (PESI) is a Predictor of Mid-Term Death After Mechano-Pharmacological Treatment of Acute Pulmonary Embolism

Hemodynamic Characteristics and Response to Catheter-Directed Lysis in Patients Presenting with Submassive Pulmonary Embolism

Special Topic: What Is the Role of Balloon Pulmonary Angioplasty for Treatment of CTEPH?

When to Employ Advanced Therapies in PE?

Emerging Catheter-Based Techniques to Treat Acute Pulmonary Embolism

Data for Lytic Therapy in Massive and Submassive Pulmonary Embolism

Acute Pulmonary Embolism: How Big Is the Problem and How to Start a PERT

Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure

Case #1 Conclusion: A Patient With Massive PE How Did We Treat?

The Case for ECMO or Other RV Support as the Ideal Treatment for Massive PE!

The Case for Surgical Therapy for Massive PE as the First-line Therapy!

The Case for Catheter-based Therapy for Massive PE as the Principal Approach!

Case #2 Introduction: A Patient With Massive PE How Should We Treat?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content